Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d, An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration

  • Buxeda, Anna|||0000-0001-7305-3259
  • Llinàs Mallol, Laura|||0000-0003-4696-3331
  • Gimeno Beltran, Javier|||0000-0001-6085-5228
  • Redondo-Pachón, Dolores|||0000-0002-0458-0052
  • Arias Cabrales, Carlos E.|||0000-0002-1729-8152
  • Burballa, Carla|||0000-0002-0091-1459
  • Puche, Adrian
  • López-Botet, Miguel|||0000-0003-4882-065X
  • Yélamos, José|||0000-0003-1195-1496
  • Vilches, Carlos|||0000-0002-0300-9225
  • Naesens, Maarten|||0000-0002-5625-0792
  • Pérez-Sáez, María José|||0000-0002-8601-2699
  • Pascual, Julio|||0000-0002-4735-7838
  • Crespo, Marta|||0000-0001-6992-6379
Isolated microvascular inflammation (iMVI) without HLA donor-specific antibodies or C4d deposition in peritubular capillaries remains an enigmatic phenotype that cannot be categorized as antibody-mediated rejection (ABMR) in recent Banff classifications. We included 221 kidney transplant recipients with biopsies with ABMR (n = 73), iMVI (n = 32), and normal (n = 116) diagnoses. We compared peripheral blood leukocyte distribution by flow cytometry and inflammatory infiltrates in kidney transplant biopsies among groups. Flow cytometry showed fewer lymphocytes and total, CD4, and CD8 peripheral T cells in iMVI compared with ABMR and normal cases. ABMR and iMVI had fewer total natural Killer (NK) cells but more NKG2A NK cells. Immunohistochemistry indicated that ABMR and iMVI had greater CD3 and CD68 glomerular infiltration than normal biopsies, whereas CD8 and TIA1 cells showed only increased iMVI, suggesting they are cytotoxic T cells. Peritubular capillaries displayed more CD3, CD56, TIA1, and CD68 cells in both ABMR and iMVI. In contrast, iMVI had less plasma cell infiltration in peritubular capillaries and interstitial aggregates than ABMR. iMVI displayed decreased circulating T and NK cells mirrored by T cell and NK cell infiltration in the renal allograft, similar to ABMR. However, the lesser plasma cell infiltration in iMVI may suggest an antibody-independent underlying stimulus.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clinical and molecular spectrum of v-lesion

  • Buxeda, Anna|||0000-0001-7305-3259
  • Crespo, Marta|||0000-0001-6992-6379
  • Chamoun, Betty|||0000-0002-4267-2273
  • Gimeno Beltran, Javier|||0000-0001-6085-5228
  • Torres, Irina B.|||0000-0003-3304-0810
  • Redondo-Pachón, Dolores|||0000-0002-0458-0052
  • Riera Oliva, Marta|||0000-0003-4362-7965
  • Burballa, Carla|||0000-0002-0091-1459
  • Pascual, Julio|||0000-0002-4735-7838
  • Mengel, Michael|||0000-0002-7222-3356
  • Adam, Benjamin|||0000-0003-1908-1739
  • Pérez-Sáez, María José|||0000-0002-8601-2699
Isolated v-lesion presents diagnostic stratification and clinical challenges. We characterized allograft outcomes for this entity based on posttransplant time (early: ≤1 month vs late:.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Gender differences in cancer risk after kidney transplantation

  • Buxeda, Anna|||0000-0001-7305-3259
  • Redondo-Pachón, Dolores|||0000-0002-0458-0052
  • Pérez-Sáez, María José|||0000-0002-8601-2699
  • Bartolomé-Solanas, Álvaro|||0000-0002-2307-0007
  • Mir, Marisa
  • Pascual-Dapena, Ana
  • Sans, Anna
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Crespo, Marta|||0000-0001-6992-6379
  • Pascual, Julio|||0000-0002-4735-7838
Kidney transplant (KT) recipients are at greater risk of developing some cancers than the general population. Moreover, cancer is the only cause of death that is currently increasing after kidney transplantation. We analyzed incidence, risk factors and characteristics of post-transplant malignancies (solid organ tumors and lymphoproliferative disorders) at our center in 925 KT recipients (1979-2014). Sex differences were particularly assessed. One hundred and eight patients (11.7%) developed solid organ tumors (76.9%) or lymphoma (23.1%). Twenty-one percent of patients who reached 20 years after KT developed cancer, with a median post-KT time to diagnosis of 7.4 years. Most common solid organs affected were lung (30.1%), prostate (10.8%), bladder (9.6%), and native kidney (7.2%). When analyzing standardized incidence ratios (SIR) by gender compared to the general population, relative risk was increased in women (SIR = 1.81; 95%CI, 1.28-2.45) but not significantly increased in men (SIR = 1.22; 0.95-2.52). Regarding specific types, gynecological (SIR = 11.6; 4.2-22.7) and lung (SIR = 10.0; 4.3-18.2) in women, and bladder (SIR = 16.3; 5.9-32.1) in men were the most affected locations. Thymoglobulin, a polyclonal antibody that has been used as an immunosuppressive agent in kidney transplantation over the last decades, was a significant risk factor for developing cancer in adjusted regression analysis [IRR = 1.62, 1.02-2.57; p = 0.041], and was associated with lower patient survival. Compared with the general population, the incidence of post-KT non-skin cancer is almost two-fold higher in women but not significantly higher in men. Lung is the most common solid organ affected. Thymoglobulin induction therapy is associated with a greater risk.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effect of bariatric surgery on cardiac structure and function in obese patients, Role of the renin-angiotensin system

  • Oliveras i Serrano, Anna|||0000-0002-5503-545X
  • Molina, Lluís
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Sans, Laia
  • Riera Oliva, Marta|||0000-0003-4362-7965
  • Vazquez, Susana
  • Benaiges, David|||0000-0001-5411-364X
  • Granados, Ana Marina
  • Ramon, José Manuel
  • Pascual, Julio|||0000-0002-4735-7838
Echocardiographic alterations have been described in obesity, but their modifications after bariatric surgery (BS) and mechanisms are little known, mostly in normotensive patients. We aimed to analyze cardiac changes 1 year post-BS and to explore possible mechanisms. A cohort of patients with severe obesity (58% normotensives) were prospectively recruited and examined before surgery and after 12 months. Clinical and echocardiographic data, 24 h BP, renin-angiotensin-aldosterone system (RAAS) components, cytokines, and inflammatory markers were analyzed at these two time points. Overall reduction in body weight was mean (IQR) = 30.0% (25.9-33.8). There were statistically significant decreases in left ventricle mass index 2.7 (LVMI) 2.7, septum thickness (ST), posterior wall thickness (PWT), relative wall thickness (RWT), and E/e', both in the whole cohort and in patients without RAAS blockers (p ≤.04 for all). Plasma renin activity (PRA) decreased from (median, IQR) = 0.8 (0.3;1.35) to 0.4 (0.2;0.93) ng/ml/h, plasma aldosterone from 92 (58.6;126) to 68.1 (56.2;83.4) ng/dl, and angiotensin-converting enzyme (ACE)-2 activity from 7.7 (5.7;11.8) to 6.8 (5.3;11.2) RFU/µl/h, p <.05. The body weight loss correlated with a decrease in both 24 h SBP and 24 h DBP (Pearson's coefficient 0.353, p =.022 and 0.384, p =.012, respectively). Variation (Δ) of body weight correlated with ΔE/e' (Pearson's coeff. 0.414, p =.008) and with Δ lateral e' (Pearson's coeff. = -0.363, p =.018). Generalized linear models showed that ΔPRA was an independent variable for the final (12-months post-BS) LVMI 2.7 (p =.028). No other changes in cardiac parameters correlated with ΔBP. In addition to the respective baseline value, final values of PWT and RWT were dependent on 12-month Δ of PRA, ACE, and ACE/ACE2 (p <.03 for all). We conclude that there are cardiac changes post-BS in patients with severe obesity, normotensives included. Structural changes appear to be related to modifications in the renin-angiotensin axis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Endothelial ADAM17 Expression in the Progression of Kidney Injury in an Obese Mouse Model of Pre-Diabetes

  • Palau, Vanesa|||0000-0002-3210-7924
  • Jarrín, Josué|||0000-0001-9172-3383
  • Villanueva, Sofia
  • Benito, David|||0000-0001-5413-5005
  • Márquez, Eva
  • Rodríguez García, Eva
  • Soler, María José|||0000-0003-3621-0766
  • Oliveras i Serrano, Anna|||0000-0002-5503-545X
  • Gimeno Beltran, Javier|||0000-0001-6085-5228
  • Sans, Laia|||0000-0002-3628-9489
  • Crespo, Marta|||0000-0001-6992-6379
  • Pascual, Julio|||0000-0002-4735-7838
  • Barrios, Clara|||0000-0003-0492-4107
  • Riera Oliva, Marta|||0000-0003-4362-7965
Disintegrin and metalloproteinase domain 17 (ADAM17) activates inflammatory and fibrotic processes through the shedding of various molecules such as Tumor Necrosis Factor-α (TNF-α) or Transforming Growht Factor-α (TGF-α). There is a well-recognised link between TNF-α, obesity, inflammation, and diabetes. In physiological situations, ADAM17 is expressed mainly in the distal tubular cell while, in renal damage, its expression increases throughout the kidney including the endothelium. The aim of this study was to characterize, for the first time, an experimental mouse model fed a high-fat diet (HFD) with a specific deletion of Adam17 in endothelial cells and to analyse the effects on different renal structures. Endothelial Adam17 knockout male mice and their controls were fed a high-fat diet, to induce obesity, or standard rodent chow, for 22 weeks. Glucose tolerance, urinary albumin-to-creatinine ratio, renal histology, macrophage infiltration, and galectin-3 levels were evaluated. Results showed that obese mice presented higher blood glucose levels, dysregulated glucose homeostasis, and higher body weight compared to control mice. In addition, obese wild-type mice presented an increased albumin-to-creatinine ratio; greater glomerular size and mesangial matrix expansion; and tubular fibrosis with increased galectin-3 expression. Adam17 deletion decreased the albumin-to-creatinine ratio, glomerular mesangial index, and tubular galectin-3 expression. Moreover, macrophage infiltration in the glomeruli of obese Adam17 knockout mice was reduced as compared to obese wild-type mice. In conclusion, the expression of ADAM17 in endothelial cells impacted renal inflammation, modulating the renal function and histology in an obese pre-diabetic mouse model.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Improvement of Arterial Stiffness One Month after Bariatric Surgery and Potential Mechanisms

  • Oliveras i Serrano, Anna|||0000-0002-5503-545X
  • Galceran, Isabel
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Vázquez, Susana
  • Sans, Laia|||0000-0002-3628-9489
  • Riera Oliva, Marta|||0000-0003-4362-7965
  • Benaiges, David|||0000-0001-5411-364X
  • Pascual, Julio|||0000-0002-4735-7838
Arterial stiffness (AS) is an independent predictor of cardiovascular risk. We aimed to analyze changes (Δ) in AS 1-month post-bariatric surgery (BS) and search for possible pathophysiological mechanisms. Patients with severe obesity (43% hypertensives) were prospectively evaluated before and 1-month post-BS, with AS assessed by pulse-wave velocity (PWV), augmentation index (AIx@75) and pulse pressure (PP). Ambulatory 24 h blood pressure (BP), anthropometric data, renin-angiotensin-aldosterone system (RAAS) components and several adipokines and inflammatory markers were also analyzed. Overall reduction in body weight was mean (interquartile range (IQR)) = 11.0% (9.6-13.1). A decrease in PWV, AIx@75 and PP was observed 1-month post-BS (all, p < 0.01). There were also significant Δ in BP, RAAS components, adipokines and inflammatory biomarkers. Multiple linear regression adjusted models showed that Δaldosterone was an independent variable (B coeff.95%CI) for final PWV (B = -0.003, -0.005 to 0.000; p = 0.022). Angiotensin-converting enzyme (ACE)/ACE2 and ACE were independent variables for final AIx@75 (B = 0.036, 0.005 to 0.066; p = 0.024) and PP (B = 0.010, 0.003 to 0.017; p = 0.01), respectively. There was no correlation between ΔAS and anthropometric changes nor with Δ of adipokines or inflammatory markers except high-sensitivity C-reactive protein (hs-CRP). Patients with PWV below median decreased PWV (mean, 95%CI = -0.18, -0.25 to -0.10; p < 0.001) and both AIx@75 and PP at 1-month, but not those with PWV above median. In conclusion, there is an improvement in AS 1-month post-BS that correlates with ΔBP and Δrenin-angiotensin-aldosterone components. The benefit is reduced in those with higher PWV.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exploring Renal Changes after Bariatric Surgery in Patients with Severe Obesity

  • Oliveras i Serrano, Anna|||0000-0002-5503-545X
  • Vázquez, Susana
  • Soler, María José|||0000-0003-3621-0766
  • Galceran, Isabel
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Benaiges, David|||0000-0001-5411-364X
  • Crespo, Marta|||0000-0001-6992-6379
  • Pascual, Julio|||0000-0002-4735-7838
  • Riera Oliva, Marta|||0000-0003-4362-7965
Obesity-related hyperfiltration leads to an increased glomerular filtration rate (GFR) and hyperalbuminuria. These changes are reversible after bariatric surgery (BS). We aimed to explore obesity-related renal changes post-BS and to seek potential mechanisms. Sixty-two individuals with severe obesity were prospectively examined before and 3, 6 and 12 months post-BS. Anthropometric and laboratory data, 24 h-blood pressure, renin-angiotensin-aldosterone system (RAS) components, adipokines and inflammatory markers were determined. Both estimated GFR (eGFR) and albuminuria decreased from the baseline at all follow-up times (p -for-trend <0.001 for both). There was a median (IQR) of 30.5% (26.2-34.4) reduction in body weight. Plasma glucose, glycosylated hemoglobin, fasting insulin and HOMA-index decreased at 3, 6 and 12 months of follow-up (p -for-trend <0.001 for all). The plasma aldosterone concentration (median (IQR)) also decreased at 12 months (from 87.8 ng/dL (56.8; 154) to 65.4 (56.8; 84.6), p = 0.003). Both leptin and hs-CRP decreased (p < 0.001) and adiponectine levels increased at 12 months post-BS (p = 0.017). Linear mixed-models showed that body weight (coef. 0.62, 95% CI: 0.32 to 0.93, p < 0.001) and plasma aldosterone (coef. -0.07, 95% CI: -0.13 to -0.02, p = 0.005) were the independent variables for changes in eGFR. Conversely, glycosylated hemoglobin was the only independent variable for changes in albuminuria (coef. 0.24, 95% CI: 0.06 to 0.42, p = 0.009). In conclusion, body weight and aldosterone are the main factors that mediate eGFR changes in obesity and BS, while albuminuria is associated with glucose homeostasis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19

  • Buxeda, Anna|||0000-0001-7305-3259
  • Arias Cabrales, Carlos E.|||0000-0002-1729-8152
  • Pérez-Sáez, María José|||0000-0002-8601-2699
  • Cacho, Judit
  • Cabello Pelegrín, Sheila|||0000-0001-9319-6935
  • Melilli, Edoardo|||0000-0001-6965-3745
  • Aladrén Regidor, Mª José|||0000-0002-1043-9979
  • Galeano Alvarez, Cristina|||0000-0003-2785-8886
  • Lorenzo, Iinmaculada
  • Mazuecos, Auxiliadora|||0000-0002-5860-2309
  • Saura, Isabel María
  • Franco, Antonio
  • Ruiz-Fuentes, María del Carmen
  • Sánchez-Cámara, Luis Alberto
  • Siverio, Orlando
  • Martin, María Luisa
  • González-García, Elena
  • López Jiménez, Verónica|||0000-0002-1793-7065
  • Martin-Moreno, Paloma Leticia
  • Moina, Iñigo
  • Moral Berrio, Esperanza
  • Moreso, Francesc|||0000-0002-7267-3963
  • Portolés, José María
  • Santana-Estupiñán, Raquel
  • Zárraga, Sofía
  • Canal Girol, Cristina|||0000-0003-2556-872X
  • Sánchez-Álvarez, Emilio
  • Pascual, Julio|||0000-0002-4735-7838
  • Crespo, Marta|||0000-0001-6992-6379
Introduction: Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury have been reported. Scant data are available on the use and safety of remdesivir in kidney transplant recipients. Methods: We present a multicenter cohort study of 51 kidney transplant recipients with COVID-19 treated with remdesivir. Outcomes and safety were assessed. Results: Mean age at diagnosis was 60 years, with a median time since kidney transplant of 4.5 years. Mean time since admission to remdesivir was 2 days. Twenty-eight patients (54.9%) required mechanical ventilation (19 noninvasive). Mortality was 18.9% and markedly higher if aged ≥65 years (45% vs. 3.2% in younger patients). Acute kidney injury was present in 27.7% of patients, but was diagnosed in 50% before treatment. No patients required remdesivir discontinuation because of adverse events. We did not find significant hepatoxicity or systemic symptoms resulting from the drug. Conclusion: In our cohort of kidney transplant recipients, remdesivir was well tolerated and safe in renal and hepatic toxicity, but randomized trials are needed to assess its efficacy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Recommendations for living donor kidney transplantation Recomendaciones para el trasplante renal de donante vivo

  • Frutos, Migeul Ángel
  • Crespo, Marta|||0000-0001-6992-6379
  • Valentín, María de la Oliva
  • Alonso-Melgar, Ángel
  • Alonso, Juana
  • Fernández, Constantino
  • García-Erauzkin, Gorka
  • González, Esther
  • González-Rinne, Ana M.
  • Guirado, Luis|||0000-0001-5119-3912
  • Gutiérrez Dalmau, Álex
  • Huguet Perez, Jordi
  • López del Moral, José Luis
  • Musquera, Mireia
  • Paredes, David
  • Redondo-Pachón, Dolores|||0000-0002-0458-0052
  • Revuelta, Ignacio|||0000-0002-3584-4516
  • Van-der Hofstadt, Carlos J.
  • Alcaraz, Antonio|||0000-0003-2612-5250
  • Alonso-Hernández, Ángel
  • Alonso, Manuel
  • Bernabeu, Purificación
  • Bernal Blanco, Gabriel
  • Breda, Alberto|||0000-0002-7842-9048
  • Cabello, Mercedes
  • Caro-Oleas, José Luis
  • Cid, Joan|||0000-0001-5445-4508
  • Diekmann, Fritz|||0000-0001-6199-3016
  • Espinosa, Laura
  • Facundo, Carme|||0000-0003-1254-5553
  • García, Marta|||0000-0001-5155-4730
  • Gil-Vernet, Salvador
  • Lozano, Miquel|||0000-0003-2593-833X
  • Mahillo, Beatriz
  • Martínez, María José
  • Miranda Serrano, Blanca
  • Oppenheimer, Federico|||0000-0002-1117-831X
  • Palou, Eduard|||0000-0003-1544-1485
  • Pérez-Sáez, María José|||0000-0002-8601-2699
  • Peri, Lluis
  • Rodríguez Faba, Óscar|||0000-0001-6668-4423
  • Santiago, Carlos
  • Tabernero, Guadalupe
  • Hernández, Domingo
  • Domínguez-Gil, Beatriz|||0000-0002-5695-8993
  • Pascual, Julio|||0000-0002-4735-7838
This Guide for Living Donor Kidney Transplantation (LDKT) has been prepared with the sponsorship of the Spanish Society of Nephrology (SEN), the Spanish Transplant Society (SET), and the Spanish National Transplant Organization (ONT). It updates evidence to offer the best chronic renal failure treatment when a potential living donor is available. The core aim of this Guide is to supply clinicians who evaluate living donors and transplant recipients with the best decision-making tools, to optimise their outcomes. Moreover, the role of living donors in the current KT context should recover the level of importance it had until recently. To this end the new forms of incompatible HLA and/or ABO donation, as well as the paired donation which is possible in several hospitals with experience in LDKT, offer additional ways to treat renal patients with an incompatible donor. Good results in terms of patient and graft survival have expanded the range of circumstances under which living renal donors are accepted. Older donors are now accepted, as are others with factors that affect the decision, such as a borderline clinical history or alterations, which when evaluated may lead to an additional number of transplantations. This Guide does not forget that LDKT may lead to risk for the donor. Pre-donation evaluation has to centre on the problems which may arise over the short or long-term, and these have to be described to the potential donor so that they are able take them into account. Experience over recent years has led to progress in risk analysis, to protect donors' health. This aspect always has to be taken into account by LDKT programmes when evaluating potential donors. Finally, this Guide has been designed to aid decision-making, with recommendations and suggestions when uncertainties arise in pre-donation studies. Its overarching aim is to ensure that informed consent is based on high quality studies and information supplied to donors and recipients, offering the strongest possible guarantees.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Redefining the Role of ADAM17 in Renal Proximal Tubular Cells and Its Implications in an Obese Mouse Model of Pre-Diabetes

  • Palau, Vanesa|||0000-0002-3210-7924
  • Villanueva, Sofia
  • Jarrín, Josué|||0000-0001-9172-3383
  • Benito, David|||0000-0001-5413-5005
  • Márquez, Eva
  • Rodríguez García, Eva
  • Soler, María José|||0000-0003-3621-0766
  • Oliveras i Serrano, Anna|||0000-0002-5503-545X
  • Gimeno Beltran, Javier|||0000-0001-6085-5228
  • Sans, Laia|||0000-0002-3628-9489
  • Soler, María José|||0000-0003-3621-0766
  • Pascual, Julio|||0000-0002-4735-7838
  • Barrios, Clara|||0000-0003-0492-4107
  • Riera Oliva, Marta|||0000-0003-4362-7965
Acute and chronic kidney lesions induce an increase in A Disintegrin And Metalloproteinase domain 17 (ADAM17) that cleaves several transmembrane proteins related to inflammatory and fibrotic pathways. Our group has demonstrated that renal ADAM17 is upregulated in diabetic mice and its inhibition decreases renal inflammation and fibrosis. The purpose of the present study was to analyze how Adam17 deletion in proximal tubules affects different renal structures in an obese mice model. Tubular Adam17 knockout male mice and their controls were fed a high-fat diet (HFD) for 22 weeks. Glucose tolerance, urinary albumin-to-creatinine ratio, renal histology, and pro-inflammatory and pro-fibrotic markers were evaluated. Results showed that wild-type mice fed an HFD became obese with glucose intolerance and renal histological alterations mimicking a pre-diabetic condition; consequently, greater glomerular size and mesangial expansion were observed. Adam17 tubular deletion improved glucose tolerance and protected animals against glomerular injury and prevented podocyte loss in HFD mice. In addition, HFD mice showed more glomerular macrophages and collagen accumulation, which was prevented by Adam17 deletion. Galectin-3 expression increased in the proximal tubules and glomeruli of HFD mice and ameliorated with Adam17 deletion. In conclusion, Adam17 in proximal tubules influences glucose tolerance and participates in the kidney injury in an obese pre-diabetic murine model. The role of ADAM17 in the tubule impacts on glomerular inflammation and fibrosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients

  • Gutiérrez-Chamorro, Lucía|||0000-0002-7649-951X
  • Riveira Muñoz, Eva|||0000-0002-6396-1162
  • Barrios, Clara|||0000-0003-0492-4107
  • Palau, Vanesa|||0000-0002-3210-7924
  • Nevot Banús, Maria|||0000-0003-4947-4648
  • Pedreño-López, Sònia|||0000-0002-1919-3530
  • Senserrich, Jordi|||0000-0002-8021-1718
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Cabrera Navarro, Cecilia|||0000-0002-9941-6828
  • Mitjà, Oriol|||0000-0003-3266-8868
  • Crespo, Marta|||0000-0001-6992-6379
  • Pascual, Julio|||0000-0002-4735-7838
  • Riera Oliva, Marta|||0000-0003-4362-7965
  • Ballana, Ester|||0000-0002-5215-7363
Angiotensin converting enzyme 2 (ACE2) is a host ectopeptidase and the receptor for the SARS-CoV-2 virus, albeit virus-ACE2 interaction goes far beyond viral entry into target cells. Controversial data exists linking viral infection to changes in ACE2 expression and function, which might influence the subsequent induction of an inflammatory response. Here, we tested the significance of soluble ACE2 enzymatic activity longitudinally in nasopharyngeal swabs and plasma samples of SARS-CoV-2 infected patients, along with the induction of inflammatory cytokines. Release of soluble functional ACE2 increases upon SARS-CoV-2 infection in swabs and plasma of infected patients, albeit rapidly decreasing during infection course in parallel with ACE2 gene expression. Similarly, SARS-CoV-2 infection also induced the expression of inflammatory cytokines. These changes positively correlated with the viral load. Overall, our results demonstrate the existence of mechanisms by which SARS-CoV-2 modulates ACE2 expression and function, intracellular viral sensing and subsequent inflammatory response, offering new insights into ACE2 dynamics in the human upper respiratory tract and pointing towards soluble ACE2 levels as a putative early biomarker of infection severity.